Status:
UNKNOWN
Transluminal Attenuation Gradient Versus CT Fractional Flow Reserve
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Samsung Medical Center
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Coronary computed tomographic angiography (CCTA) has emerged as a non-invasive test, accurately evaluate anatomic coronary artery stenosis. However, anatomically-obstructive coronary stenosis by CCTA ...
Detailed Description
Angiographically obtained fractional flow reserve (FFR) is a useful physiologic test for assessment of lesion-specific ischemia, and a valuable adjunct to anatomic assessment of coronary artery diseas...
Eligibility Criteria
Inclusion
- Age \>= 18 years old
- CCTA with \>=50% stenosis in a major coronary artery (\>=2.0 mm diameter)
- underwent invasive coronary angiography with FFR measurement
Exclusion
- with CCTA of poor image quality
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01413334
Start Date
May 1 2011
End Date
December 1 2011
Last Update
August 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744